Literature DB >> 12782910

Fibrosis associated with dopamine agonist therapy in Parkinson's disease.

Thomas Müller, Jürgen Fritze.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12782910     DOI： 10.1097/00002826-200305000-00001

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN： 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  5 in total

1.  Inflammatory aneurysm of the abdominal aorta in a patient treated with ropinirole.

Authors:  Dimitrios Parissis; Athanasia Papachristodoulou; Athanasios Dimitriadis
Journal:  J Neurol       Date:  2010-04-21       Impact factor: 4.849

Review 2.  Role of pramipexole in the management of Parkinson's disease.

Authors:  Angelo Antonini; Paolo Barone; Roberto Ceravolo; Giovanni Fabbrini; Michele Tinazzi; Giovanni Abbruzzese
Journal:  CNS Drugs       Date:  2010-10       Impact factor: 5.749

Review 3.  Ropinirole, a non-ergoline dopamine agonist.

Authors:  Wolfgang H Jost; Dieter Angersbach
Journal:  CNS Drug Rev       Date:  2005

Review 4.  Cabergoline : a review of its use in the treatment of Parkinson's disease.

Authors:  Monique P Curran; Caroline M Perry
Journal:  Drugs       Date:  2004       Impact factor: 9.546

5.  Drug therapy in patients with Parkinson's disease.

Authors:  Thomas Müller
Journal:  Transl Neurodegener       Date:  2012-05-24       Impact factor: 8.014
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.